PeptideSupplierMatch

Peptide Intelligence

Peptide Dosing Protocols

Reference guide for commonly cited dosing ranges, routes of administration, cycling protocols, and reconstitution guidance. For educational purposes only — always consult a licensed provider.

SemaglutideFDA Approved
GLP-1 Receptor Agonist

Subcutaneous (Wegovy)

Common Range

Timing

Frequency

Cycling

Storage

Inject in abdomen, thigh, or upper arm. Rotate injection sites.

View Full Profile Check Interactions
TirzepatideFDA Approved
Dual GIP/GLP-1 Receptor Agonist

Subcutaneous (Zepbound)

Common Range

Timing

Frequency

Cycling

Storage

Inject in abdomen, thigh, or upper arm. Rotate injection sites.

View Full Profile Check Interactions
SermorelinFDA Approved (Diagnostic)
GHRH Analog

Subcutaneous

Common Range

Timing

Frequency

Cycling

Reconstitution

Storage

Evening administration aligns with natural GH pulse during sleep. Start at lower end and titrate based on IGF-1 response.

View Full Profile Check Interactions
TesamorelinFDA Approved
GHRH Analog

Subcutaneous

Common Range

Timing

Frequency

Cycling

Reconstitution

Storage

FDA-approved dose is 2mg daily. Rotate injection sites on abdomen.

View Full Profile Check Interactions

Full Dosing Protocols — For Healthcare Professionals

Access detailed dose ranges, cycling schedules, reconstitution instructions, and clinical considerations for all 51 peptide therapies.

Sign InClaim Your Listing
Verified Providers OnlyUpdated March 2026
BPC-157
Tissue Repair & Regeneration

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

TB-500
Tissue Repair & Regeneration

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

CJC-1295
GH Secretagogue

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Ipamorelin
GH Secretagogue

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Thymosin Alpha-1
Immune Modulator

Subcutaneous

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

GHK-Cu
Tissue Repair / Anti-Aging

Topical

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

AOD 9604
GH Fragment / Weight Management

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

PT-141
Sexual Health

Subcutaneous

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Epitalon
Anti-Aging

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Melanotan II
Tanning / Sexual Health

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

MOTS-c
Metabolic / Exercise Mimetic

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Liraglutide
GLP-1 Receptor Agonist

Subcutaneous (Saxenda)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Exenatide
GLP-1 Receptor Agonist

Subcutaneous (Byetta)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

MK-677
GH Secretagogue (Ghrelin Mimetic)

Oral (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Hexarelin
GH Secretagogue (GHRP)

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

GHRP-6
GH Secretagogue (GHRP)

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

GHRP-2
GH Secretagogue (GHRP)

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Kisspeptin-10
Hormone Modulator (GnRH Stimulant)

Subcutaneous/IV (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Selank
Nootropic / Anxiolytic Peptide

Intranasal

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Semax
Nootropic / Neuroprotective Peptide

Intranasal

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Dihexa
Nootropic / Cognitive Enhancer

Oral/Sublingual/Intranasal (research context only)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

LL-37
Antimicrobial Peptide

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

KPV
Anti-Inflammatory Peptide

Oral capsule (research/clinical context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Pentosan Polysulfate
Tissue Repair / Glycosaminoglycan

Oral (Elmiron, FDA-approved for IC)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Subcutaneous/IM (off-label, joint health)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

NAD+
Metabolic Cofactor

Intravenous infusion

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Subcutaneous injection

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

SS-31
Mitochondrial-Targeted Peptide

Subcutaneous (clinical trial dosing)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

VIP
Immune / Neuro Modulator

Intranasal (CIRS/Shoemaker protocol)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Cerebrolysin
Neuroprotective Peptide Complex

Intravenous infusion

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

DSIP
Sleep / Recovery Peptide

Subcutaneous (research context)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Follistatin 344
Myostatin Inhibitor / Muscle Growth

Subcutaneous (research context — no validated protocol)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Bremelanotide
Melanocortin Receptor Agonist (Sexual Health)

Subcutaneous (Vyleesi autoinjector)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Oxytocin
Neuropeptide Hormone

IV (Pitocin — obstetric, FDA-approved)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Intranasal (behavioral/psychiatric — off-label)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Thymalin
Immune Modulator (Thymic Peptide)

Intramuscular (Russian protocol)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

PE-22-28
Nootropic / Antidepressant Peptide

Intranasal (research context — NO validated human protocol)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

5-Amino-1MQ
Metabolic / Weight Management (Small Molecule)

Oral (research context — NO validated human protocol)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Retatrutide
Triple Incretin Receptor Agonist (GLP-1/GIP/Glucagon)

Subcutaneous (Phase II trial dosing)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

CJC-1295 + Ipamorelin
GH Secretagogue Combination

Subcutaneous (clinical protocol)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

AHK-Cu
Hair & Skin Peptide

Topical (scalp/skin)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Snap-8
Cosmetic / Anti-Wrinkle Peptide

Topical (facial application)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Palmitoyl Pentapeptide-4
Skin / Collagen-Stimulating Peptide

Topical (facial/body application)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

FOXO4-DRI
Senolytic Peptide

Subcutaneous (Research Protocol)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Glutathione
Endogenous Tripeptide Antioxidant

Intravenous

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Subcutaneous

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Humanin
Mitochondrial-Derived Peptide

Subcutaneous (Research)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

CagriSema
Amylin Analog + GLP-1 Receptor Agonist (Combination)

Subcutaneous

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Survodutide
Dual GLP-1/Glucagon Receptor Agonist

Subcutaneous

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Argireline
Cosmeceutical Peptide

Topical (facial application)

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Pinealon
Bioregulator Peptide

Oral/Sublingual

Common Range

●●● mcg / ●●● IU

Timing

●●● mcg / ●●● IU

Frequency

●●● mcg / ●●● IU

Cycling

●●● mcg / ●●● IU

Ready to start a protocol?

Work with a verified provider who can guide your dosing.

Get Matched

Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider before starting, stopping, or modifying any peptide therapy. PeptideSupplierMatch does not prescribe, sell, or distribute peptides.

Ready to Navigate the Peptide Space?

Whether you're sourcing suppliers or finding providers, start your journey with confidence today.

Claim Your ListingFind a SupplierFind Providers